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Introduction 
Identifying agents that inhibit the 
proliferation of stem cells is of great importance 
in regenerative medicine.  In addition, 
identifying agents that increase the expression 
of miRNAs to inhibit cancer stem cell (CSC) 
proliferation is of great importance in cancer 
biology.  
Curcumin has been shown to function as an 
anti-cancer agent.  However, its mechanism of 
action remains elusive.   
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Hypothesis 
Curcumin has been shown to function as an anti-
cancer/inflammatory/diabetic agent (Figure 1).  
However, it is not known whether it inhibits cancer 
stem cell (CSCs) proliferation to inhibit caner 
proliferation.  Here, I propose for the first time that 
Curcumin: a) inhibits CSCs proliferation; and b) 
increases miRNA processing.  Thereby, it increases 
the expression of a number of miRNAs to control 
the proliferation of CSCs.  
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Results-1 
The tumor suppressors that appear to be induced in response to 
curcumin treatment are p53 and TA-p73.  A recent study suggests that 
curcumin increases the expression of miRNAs, such as miR-22, miR-
181a, b, c, miR-15/16a, miR-34, miR-103, and miR-21(Figure 2).   
Intriguingly, miR-34, 181-b, c, miR-103, miR-21, miR-15/16a, and 
miR-24 have been identified as transcriptional targets of the tumor 
suppressor p53.  This data suggests a possibility that curcumin, by 
inducing the expression of p53/p73, it could increase the expression of 
these microRNAs (Figure 2).   
A number of groups have shown that c-Myc, Sox-2, Klf-4, Oct-4, 
Sox-2, Nanog, and Lin28 are required for reprogramming of 
differentiated cells into pluripotent stem cells and for cancer stem cell 
proliferation.  Interestingly, miR-21 has recently been shown to 
represses stem cell factors such as Oct4, Nanog, sox2, and c-Myc, 
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indicating that curcumin by increasing the expression of miR-21, it 
could inhibit cancer stem cell proliferation.   
Results-2 
In addition, curcumin induced p53/TA-p73 may result in increased 
expression of its target, miR-145.  Interestingly, it has recently been 
shown that miR-145 suppresses the expression of c-myc, klf-4, Oct-4, 
and Sox-2 in human embryonic stem cells (hESCs) and thereby 
promotes the differentiation of hESC.   
This data suggests that p53/p73-dependent miR-145 expression 
will result in down regulation of Oct-4, Klf-4, Sox-2, Nanog, and c-myc 
and inhibition of stem cell proliferation (Figure 3).   
Further, curcumin induced miR-22 appears to inhibit the 
expression of estrogen receptor α.  Remarkably, it has recently been 
shown that estrogen receptor α inhibits the processing of several 
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microRNAs, including the tumor suppressor miR-145(Figure 3).  In 
addition, Curcumin- a) induced miR-15/16a appears to inhibit the 
expression of the negative regulator of INK4a/ARF, BMI (figure 4); and 
b) inhibited NFKB activity appears to inhibit the expression of lin-28 and 
thereby induce the tumor suppressor let-7 expression (figure 4).  
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Conclusion 
This data suggests that curcumin, by inhibiting 
the expression of estrogen receptor α through its 
target miR-22, it could increase the processing of 
miR-145 and down regulate the expression of its 
target genes (Oct-4, Klf-4, Sox-2, Nanog, and c-myc).  
In addition, it may increase the processing of let-7 
by inhibiting the NFKB-dependent lin-28 expression.  
Thereby, curcumin could function as a positive 
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regulator of miRNA processing and a negative 
regulator of cancer stem cell proliferation.  
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